PL366889A1 - Nowy kryształ pochodnej aryloetenosulfonoamidu i sposób jego otrzymywania - Google Patents

Nowy kryształ pochodnej aryloetenosulfonoamidu i sposób jego otrzymywania

Info

Publication number: PL366889A1
Authority: PL; Poland
Prior art keywords: producing; same; novel crystal; pyrimidin; arylethenesulfonamide
Prior art date: 2001-07-27

Application number

PL02366889A

Other languages

English (en)

Inventor

Yoshinori Kato

Hironori Harada

Masahiro Kurotani

Haruhiko Toda

Kenichirou Sakamoto

Original Assignee

Yamanouchi Pharmaceutical Co, Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-27

Filing date

2002-07-25

Publication date

2005-02-07

2002-07-25 Application filed by Yamanouchi Pharmaceutical Co, Ltd. filed Critical Yamanouchi Pharmaceutical Co, Ltd.

2005-02-07 Publication of PL366889A1 publication Critical patent/PL366889A1/pl

Links

239000013078 crystal Substances 0.000 title abstract 2
VYINJEQHBDPEBO-SAPNQHFASA-N (e)-n-[5-(2-ethoxyphenoxy)-6-methoxy-2-pyrimidin-2-ylpyrimidin-4-yl]-2-phenylethenesulfonamide Chemical compound CCOC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OC)=C1NS(=O)(=O)\C=C\C1=CC=CC=C1 VYINJEQHBDPEBO-SAPNQHFASA-N 0.000 abstract 1
LONWRQOYFPYMQD-DTQAZKPQSA-N (e)-n-[6-methoxy-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]-2-phenylethenesulfonamide Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OC)=C1NS(=O)(=O)\C=C\C1=CC=CC=C1 LONWRQOYFPYMQD-DTQAZKPQSA-N 0.000 abstract 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

PL02366889A 2001-07-27 2002-07-25 Nowy kryształ pochodnej aryloetenosulfonoamidu i sposób jego otrzymywania PL366889A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2001227253		2001-07-27

Publications (1)

Publication Number	Publication Date
PL366889A1 true PL366889A1 (pl)	2005-02-07

Family

ID=19059947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02366889A PL366889A1 (pl)	2001-07-27	2002-07-25	Nowy kryształ pochodnej aryloetenosulfonoamidu i sposób jego otrzymywania

Country Status (14)

Country	Link
US (1)	US7232904B2 (pl)
EP (1)	EP1413578A4 (pl)
JP (1)	JPWO2003010152A1 (pl)
KR (1)	KR100757701B1 (pl)
CN (1)	CN1245389C (pl)
BR (1)	BR0211489A (pl)
CA (1)	CA2452253C (pl)
HU (1)	HUP0400869A3 (pl)
MX (1)	MXPA04000650A (pl)
NO (1)	NO20040346L (pl)
PL (1)	PL366889A1 (pl)
RU (1)	RU2004105867A (pl)
WO (1)	WO2003010152A1 (pl)
ZA (1)	ZA200309902B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004010194A1 (de) *	2004-03-02	2005-10-13	Aventis Pharma Deutschland Gmbh	4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
DE102004010207A1 (de) *	2004-03-02	2005-09-15	Aventis Pharma S.A.	Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
CA2602097A1 (en) *	2005-03-22	2006-09-28	Daiichi Sankyo Company, Limited	Process for producing carbapenem derivatives having 1-alkylpyrrolidine structure
TW200639176A (en) *	2005-05-13	2006-11-16	Sankyo Co	Crystal of 1-methyl carbapenem compound
CN111689934B (zh) *	2020-06-24	2022-08-02	郑州大学	14-脱羟-13-脱氢穿心莲内酯-12-磺酸钾的单晶体及制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3087968B2 (ja) *	1995-12-20	2000-09-18	山之内製薬株式会社	アリールエテンスルホンアミド誘導体及びその医薬組成物

2002
- 2002-07-25 CA CA002452253A patent/CA2452253C/en not_active Expired - Fee Related
- 2002-07-25 PL PL02366889A patent/PL366889A1/pl not_active Application Discontinuation
- 2002-07-25 MX MXPA04000650A patent/MXPA04000650A/es not_active Application Discontinuation
- 2002-07-25 JP JP2003515511A patent/JPWO2003010152A1/ja active Pending
- 2002-07-25 WO PCT/JP2002/007551 patent/WO2003010152A1/ja not_active Ceased
- 2002-07-25 RU RU2004105867/04A patent/RU2004105867A/ru not_active Application Discontinuation
- 2002-07-25 US US10/484,836 patent/US7232904B2/en not_active Expired - Fee Related
- 2002-07-25 EP EP02751685A patent/EP1413578A4/en not_active Withdrawn
- 2002-07-25 HU HU0400869A patent/HUP0400869A3/hu unknown
- 2002-07-25 CN CNB028149556A patent/CN1245389C/zh not_active Expired - Fee Related
- 2002-07-25 KR KR1020047001114A patent/KR100757701B1/ko not_active Expired - Fee Related
- 2002-07-25 BR BR0211489-5A patent/BR0211489A/pt not_active Application Discontinuation
2003
- 2003-12-22 ZA ZA200309902A patent/ZA200309902B/en unknown
2004
- 2004-01-26 NO NO20040346A patent/NO20040346L/no unknown

Also Published As

Publication number	Publication date
EP1413578A4 (en)	2004-10-20
JPWO2003010152A1 (ja)	2004-11-18
MXPA04000650A (es)	2004-03-19
NO20040346L (no)	2004-03-24
HUP0400869A3 (en)	2004-10-28
CA2452253C (en)	2009-06-02
CA2452253A1 (en)	2003-02-06
EP1413578A1 (en)	2004-04-28
BR0211489A (pt)	2004-08-17
US20040162302A1 (en)	2004-08-19
US7232904B2 (en)	2007-06-19
KR20040018514A (ko)	2004-03-03
HUP0400869A2 (hu)	2004-07-28
WO2003010152A1 (en)	2003-02-06
ZA200309902B (en)	2005-03-14
KR100757701B1 (ko)	2007-09-14
CN1535265A (zh)	2004-10-06
CN1245389C (zh)	2006-03-15
RU2004105867A (ru)	2005-06-27

Similar Documents

Publication	Publication Date	Title
SG167664A1 (en)	2011-01-28	2,4-pyrimidinediamine compounds and their uses
IL160872A0 (en)	2004-08-31	Pyrimidinones as melanin concentrating hormone receptor 1
DE60112974D1 (en)	2005-09-29	Carbolinderivate
IL166710A0 (en)	2006-01-15	Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
MXPA05011643A (es)	2005-12-15	5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension.
DE60216233D1 (en)	2007-01-04	Carbolinderivate
PL371127A1 (pl)	2005-06-13	Pochodne 6-amino-morfinianu, metody ich otrzymywania oraz ich zastosowania
MXPA04002256A (es)	2004-07-23	Uso de gonadotropina corionica humana (gch) en hiperestimulacion ovarica controlada.
MXPA05011212A (es)	2006-03-30	Derivados de indeno como agentes farmaceuticos.
PL366889A1 (pl)	2005-02-07	Nowy kryształ pochodnej aryloetenosulfonoamidu i sposób jego otrzymywania
AU2001263139A1 (en)	2001-12-03	Novel synthesis of heteroarylamine intermediate compounds
YU21104A (sh)	2006-08-17	Upotreba hcg i lh u kontrolisanoj hiperstimulaciji ovarijuma
AU2003240634A1 (en)	2003-12-02	Method for producing bicalutamide
WO2004092121A3 (en)	2005-04-14	Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
AU2001262081A1 (en)	2001-09-12	Method for producing beta-alaninamides
EP1411153A4 (en)	2006-11-02	METHOD FOR PRODUCING A GAIN-BASED COMPOUNDER SEMICONDUCTOR CRYSTAL
MXPA04003085A (es)	2004-09-06	Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
MXPA04004526A (es)	2004-08-11	N-metil-homocisteinas, su uso y metodo para su produccion.
MXPA01008308A (es)	2003-06-06	Proceso para la preparacion de compuestos de 6-(perfluoroalquil) uracilo.
UA80871C2 (en)	2007-11-12	5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
AU2001286889A1 (en)	2002-03-13	Process and intermediates for preparing retroviral protease inhibitors
AU2003222399A1 (en)	2004-11-26	Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides
AU2003272991A1 (en)	2004-05-04	Process for producing n-(2-amino-1,2-dicyanovinyl)formamidine
SG145572A1 (en)	2008-09-29	Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same

Legal Events

Date	Code	Title	Description
2011-05-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)